For example, high expression of EGFR ligands, especially amphiregulin, supports proliferation of colorectal cancer (CRC) cells and might predict response to a combination of chemotherapy plus an anti-EGFR mAb, such as cetuximab [11]. This evidence concerns the gene EGFR and colorectal carcinoma.